跳至主要内容
临床试验/IRCT20171014036753N2
IRCT20171014036753N2招募中3 期

comparison of effects of nebulised Frusemide and placebi in patients with acute dyspnea transmited by EMS

Iran University of Medical Sciences0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • all patient between 18 to 75 years old with dyspnea who transmitted to hospitals by EMS

排除标准

  • not willing to participate in the study
  • history of susceptibility to sulfa drugs
  • unstable hemodynamics; requiring mechanical ventilation; decreased consciousness, accompany with another illness requiring treatment in the first 10 minutes of treatment with digoxin, beta blocker, beta-agonist and calcium; need to have another inhaling treatment in the first 10 minutes and need to have non-invasive ventilation.

研究者

相似试验